Umer Raffat
Stock Analyst at Evercore ISI
(4.11)
# 1,648
Out of 4,696 analysts
163
Total ratings
52.4%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by Umer Raffat
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEVA Teva Pharmaceutical Industries | Maintained: Buy | n/a | $36.19 | - | 10 | Sep 2, 2026 | |
| APMD Apnimed | Initiated Coverage: Buy | n/a | $26.85 | - | 1 | Aug 25, 2026 | |
| LLY Eli Lilly and Company | Maintained: Hold | n/a | $1,160.00 | - | 14 | Aug 6, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $149.92 | - | 16 | Aug 5, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | n/a | $39.47 | - | 1 | Jul 6, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | n/a | $88.50 | - | 6 | Jun 3, 2026 | |
| PCVX Vaxcyte | Maintained: Buy | n/a | $60.81 | - | 2 | May 21, 2026 | |
| BIIB Biogen | Initiated Coverage: Buy | n/a | $216.04 | - | 8 | May 15, 2026 | |
| KLRA Kailera Therapeutics | Initiated Coverage: Buy | n/a | $16.41 | - | 1 | May 12, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | n/a | $23.91 | - | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $438.12 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.01 | - | 6 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $28.55 | - | 8 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.76 | - | 7 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.06 | - | 3 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.49 | +82.15% | 3 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $62.32 | - | 3 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $47.20 | - | 6 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.57 | - | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $29.71 | - | 6 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.7081 | - | 2 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $22.64 | n/a | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.61 | n/a | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $149.86 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $17.88 | n/a | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $33.81 | n/a | 4 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $9.39 | n/a | 5 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $21.13 | n/a | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.63 | n/a | 6 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $243.71 | n/a | 5 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $150.55 | n/a | 3 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.04 | n/a | 2 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $23.03 | n/a | 1 | Mar 9, 2018 |
Teva Pharmaceutical Industries
Sep 2, 2026
Maintained: Buy
Price Target: n/a
Current: $36.19
Upside: -
Apnimed
Aug 25, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $26.85
Upside: -
Eli Lilly and Company
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $1,160.00
Upside: -
Gilead Sciences
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $149.92
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $39.47
Upside: -
Spyre Therapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $88.50
Upside: -
Vaxcyte
May 21, 2026
Maintained: Buy
Price Target: n/a
Current: $60.81
Upside: -
Biogen
May 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $216.04
Upside: -
Kailera Therapeutics
May 12, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $16.41
Upside: -
Elanco Animal Health
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $23.91
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $438.12
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $9.01
Upside: -
Apr 27, 2026
Maintained: Buy
Price Target: n/a
Current: $28.55
Upside: -
Apr 10, 2026
Maintained: Hold
Price Target: n/a
Current: $13.76
Upside: -
Mar 27, 2026
Maintained: Buy
Price Target: n/a
Current: $37.06
Upside: -
Mar 9, 2026
Maintained: Buy
Price Target: $10
Current: $5.49
Upside: +82.15%
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $62.32
Upside: -
Nov 12, 2025
Maintained: Buy
Price Target: n/a
Current: $47.20
Upside: -
Nov 11, 2025
Maintained: Buy
Price Target: n/a
Current: $25.57
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $29.71
Upside: -
Sep 30, 2025
Maintained: Buy
Price Target: n/a
Current: $0.7081
Upside: -
May 12, 2025
Maintained: Buy
Price Target: n/a
Current: $22.64
Upside: n/a
Feb 21, 2025
Maintained: Buy
Price Target: n/a
Current: $9.61
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $149.86
Upside: n/a
Oct 15, 2024
Upgraded: Buy
Price Target: n/a
Current: $17.88
Upside: n/a
Mar 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $33.81
Upside: n/a
May 11, 2023
Upgraded: Buy
Price Target: n/a
Current: $9.39
Upside: n/a
Nov 1, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $21.13
Upside: n/a
Dec 9, 2021
Maintained: Buy
Price Target: n/a
Current: $16.63
Upside: n/a
Jan 28, 2021
Maintained: Buy
Price Target: n/a
Current: $243.71
Upside: n/a
Jul 20, 2020
Reiterated: Buy
Price Target: n/a
Current: $150.55
Upside: n/a
Jun 4, 2019
Maintained: Buy
Price Target: n/a
Current: $4.04
Upside: n/a
Mar 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $23.03
Upside: n/a